InterAx Biotech AG Revenue and Competitors
Estimated Revenue & Valuation
- InterAx Biotech AG's estimated annual revenue is currently $3.3M per year.
- InterAx Biotech AG's estimated revenue per employee is $155,000
Employee Data
- InterAx Biotech AG has 21 Employees.
- InterAx Biotech AG grew their employee count by -12% last year.
InterAx Biotech AG's People
| Name | Title | Email/Phone |
|---|
InterAx Biotech AG Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is InterAx Biotech AG?
InterAx Biotech AG is a Swiss company and spinoff from the ETH Zurich and the Paul Scherrer Institute (PSI). InterAx is uniquely positioned to assist drug candidate design and selection by integrating bioanalytical and computational pharmacology in partnership projects with Biotech and Pharma companies. InterAx applies mathematical models and simulations to in house-derived bioanalytical data in order to address the complexity of drug-induced cellular signaling mechanisms. Our goal is to close the gap between laboratory experiments and in vivo studies by streamlining the critical processes of drug candidate design and selection, thereby significantly reducing the risks, costs and duration of drug discovery and development of new drugs.
keywords:N/A
N/A
Total Funding
21
Number of Employees
$3.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator